Decision Resources, Inc., June 2009, Pages: 37
For decades, the efficacy of hormone replacement therapy (HRT) for some of menopause’s most troublesome symptoms eliminated any incentive to develop new approaches to treatment. However, data
Global Industry Analysts, Inc., Sep 2008, Pages: 425
developments. Annotated with quantitative analysis and research findings, the discussion on the US market contains 46 market data tables designed to give the reader a macro level understanding
John Wiley and Sons Ltd, July 2007, Pages: 276
, Contemporary Drug Synthesis, but with all new therapeutic categories and drugs discussed.
About the Authors:
Douglas S. Johnson, PHD, is a Research Chemist at Pfizer Global Research and Development.
Jie Jack
John Wiley and Sons Ltd, Jan 2011, Pages: 520
This book is a compilation of summarized analytical methods designed to serve the needs of pharmacologists, toxicologists, and other allied health professionals involved the development, use
GlobalData, Sep 2011, Pages: 36
Pharmaceutical company, engaged in the manufacture of active pharmaceutical ingredients (APIs) and its intermediates and enteric coating excipients. Its product portfolio includes Ibuprofen, Gabapentin, Ranitidine
John Wiley and Sons Ltd, March 2008, Pages: 272
, the summary of its industrial development, the year put into practice, the biological target for the medicine, the human proteins related to the disease, the metabolism or action of the condition treated
Business Horizons, Jan 2008, Pages: 540
Successful drug formulation development takes more than a great idea. It takes technology, know-how and manufacturing experience to find the best route for your product. It also takes regulatory
GlobalData, June 2011, Pages: 121
corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.
This report
